Additional file 2 of A gene mutation-based risk model for prognostic prediction in liver metastases

Additional file 2: Table S1. The clinical data for each sample used in the training cohort. Table S2. The clinical data for each sample used in the validation cohort. Table S3. The clinical data for each sample used in the primary liver cancer cohort. Table S4. Gene list for FUSCC. Table S5. The clinical data for breast cancer liver metastases in the cohort of Pleasance et al. Table S6. Gene list for MSKCC. Table S7. Immune-related signatures used in the study. Table S8. The multivariate Cox regression analysis of gene mutations in patients with liver metastasis. Table S9. Functional enrichment analysis of differential expressed genes between the high- and low-risk group in the transcriptomic cohort.